Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10018193HBVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS20013017HPVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS20021008HPVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS20013016HPVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS20062745HPVENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TVIS44020000HTLV-1ENSG00000082556.14protein_codingOPRK1NoNo4986P41145
TCGA Plot Options
Drug Information
GeneOPRK1
DrugBank IDDB00370
Drug NameMirtazapine
Target IDBE0000632
UniProt IDP41145
Regulation Typeagonist
PubMed IDs12372565; 22708686; 30155392
CitationsSchreiber S, Rigai T, Katz Y, Pick CG: The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms. Brain Res Bull. 2002 Sep 30;58(6):601-5.@@Olianas MC, Dedoni S, Onali P: The atypical antidepressant mianserin exhibits agonist activity at kappa-opioid receptors. Br J Pharmacol. 2012 Nov;167(6):1329-41. doi: 10.1111/j.1476-5381.2012.02078.x.@@Peckham AM, De La Cruz A, Dufresne RL: Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression? Ment Health Clin. 2018 Jun 29;8(4):175-183. doi: 10.9740/mhc.2018.07.175. eCollection 2018 Jul.
GroupsApproved
Direct ClassificationPiperazinoazepines
SMILESCN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1
PathwaysMirtazapine H1-Antihistamine Action
PharmGKBPA450522
ChEMBLCHEMBL654